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Abstract
Background: Recent neuroinformatic studies, on the structure-function interaction of proteins, causative agents basis of human
disease have implied that dysfunction or defect of different protein classes could be associated with several related diseases.
Objectives: The aim of this study was the use of bioinformatics approaches for understanding the structure, function and relation-
ship of myelin protein 2 (PMP2), a myelin-basic protein in the basis of neuronal disorders.
Methods: A collection of databases for exploiting classification information systematically, including, protein structure, protein
family and classification of human disease, based on a new approach was used. Knowledge discovery was carried out based on
collections criteria and in silico integrative in vitro studies.
Results: The results of the evaluation of bioinformatics comorbid proteomics studies revealed that PMP2, an intracellular and mem-
brane myelin protein, is specific for a neuritis disease and collaborative to other diseases. Leprosy, another neuronal disease that
could be related to neuritis, consists of interferon gamma (IFNG), a secreted protein included various protein classes from what is
neuritis.
Conclusions: The growth rate of information in bioinformatics databases could facilitate studies of live organisms prior to ob-
servation studies. Two different protein classes could be causative agents of one disease. However, two related diseases from one
disease group could consist of different protein classes. Future research in the field of proteomics could allow modern insight to
reshuﬄing of proteins in different diseases, and lead to the discovery of the etiology of such diseases.
Keywords: Bioinformatics Databases, Myelin Protein 2 (PMP2), Protein Classes, Human Disorders
1. Background
The myelin sheath is a dynamic entity multilayered
membrane in the vertebrate nervous system that is pro-
duced by and extends from Oligodendrocytes (OLG) in-
cluding the lipid-rich (approx. 70% of its dry weight) (1, 2)
several hundreds of proteins (3), and has unique biochem-
ical properties (4).
In the past decades, advances of bioinformatics tools
in the study of proteomics marked the beginning of a
quiet revolution of biological investigation, in which re-
searchers systematically studied organisms on different
levels, including genomes (5), transcriptomes (6), pro-
teomes protein expressions (7), metabolomes (8) and in-
teractomes (9). Since, most physiological and pathologi-
cal processes are manifested at the protein level, biologi-
cal scientists are rapidly becoming interested in applying
proteomic techniques in combination with bioinformat-
ics studies to foster a better understanding of basic molec-
ular biology, for numerous diseases (10, 11) and protein lev-
els, and they can give a fairly complete view of living organ-
isms (12-14).
Recent studies have implied that myelin biogenesis is
a carefully regulated process, related to the presence of
a group of proteins neuro-targets, which are mainly ex-
pressed by myelinating cells in myelin sheath. They are
generally thought of as “myelin-specific protein” (15, 16)
and are located in the central nervous system (CNS) and pe-
ripheral nervous system (PNS).
Myelin protein 2 (P2) or peripheral myelin protein
(PMP2) is a “myelin-specific protein” in the basis of neu-
ronal disorders with high abundance in PNS myelin (17). Al-
though, detailed P2 membrane-binding mechanism is un-
known; its structure in different species, by biochemical
techniques is known (18).
The structure-function studies of this protein revealed
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that a small, basic (19) and a peripheral membrane protein,
as it is a fatty acid binding protein (FABP) including lipid
transport myelin (17). Moreover, it is the crucial antigen in-
volved in the induction of experimental allergic neuritis,
which is an autoimmune disease of the peripheral nervous
system (20).
Evidence observation with consolidate basis displayed
that intravenous administration of 100 microgram of re-
combinant P2 protein twice daily, could completely pre-
vent experimental autoimmune neuritis induced by adop-
tive transfer of neuritogenic P2-specific T cells or by immu-
nization with the neuritogenic P2-peptidespanning amino
acids 53 - 78 (21).
The human PMP2 gene was allocated to chromosome
8q21.3-q22.1 (19), as a candidate gene for autosomal reces-
sive Charcot-Marie-Tooth disease type 4A (18, 22).
There are various distinct PMPs, thrombin-induced
PMP-1 [tPMP-1], PMP-2 and human neutrophil defensin-1
(hNP-1), which are accomplished with membrane damage
with different mechanisms (23). Exonic Single nucleotide
Polymorphisms (SNPs) at positions 220 (A/G) and 445 (C/T)
of the peripheral myelin protein 2 (PMP2) (24) are de-
scribed with the application of single-strand conforma-
tion polymorphism (SSCP) analysis (25, 26). In addition,
using SSCP and physical map, has demonstrated that the
myelin protein PMP-2, mapped by fluorescent in situ hy-
bridization (FISH) to transformation region in acute trans-
verse myelopathy (ATM), is not the defect in CMT4A (25-27).
Lymphocytes from patients with acute ATM were shown
to undergo a specific and significant transformation when
cultured in vitro in the presence of either the central ner-
vous myelin basic encephalitogenic protein or the periph-
eral nerve myelin P2 protein (20).
In the past decade, evidence based on experimental ob-
servation of the disease related to PMP2, revealed that this
myelin-specific protein could be highly related to neuritis
disease.
Neuritis, a general inflammation of the peripheral ner-
vous system, and sensorineural hearing loss is associated
with an important gene, PMP2; affiliated tissues include T-
cells and brain. Neuritis is characterized by different nerve
symptoms including pain, paresthesia, paresis, hypoesthe-
sia, anesthesia, paralysis, wasting and disappearance of re-
flexes. Physical and chemical injuries, comorbid environ-
ment factors and collection of disease have been consid-
ered as causes of neuritis (28). Moreover, neuritis consists
of four types of clinical features including brachial, cra-
nial, optic and vestibular neuritis (29). Also, this neuronal
disease is related to a collection of family proteins, which
may be considered as an etiology of disease.
Leprosy, a neural and infectious disease, could be trans-
mitted by aerosol spread from infected nasal secretions to
exposed nasal and oral mucosa. The types of infection lep-
rosy include lesions in superficial peripheral nerves, skin,
mucous membranes of the upper respiratory tract, ante-
rior chamber of the eyes, or testes. Interferon Gama, a fam-
ily of secreted proteins, is associated with Leprosy (30).
2. Objectives
The focus of this study was on bioinformatics ap-
proaches for understanding the structure, function and re-
lationship of Myelin Protein 2 (PMP2), with other protein
families, assumed to be involved in the basis of neuronal
disorders.
3. Methods
The basic method in this study was the application of
bioinformatics databases and tools. We used the follow-
ing databases to predict peptides’ protein structure, hu-
man disease, proteomic peptide analysis and reciprocal
proteins: Expasy, HPRD, KEGG, NCBI, OMIM, PDB, PeptideAt-
las, and UniProtKB. Moreover, a set of documents related to
protein classes, myelin proteins, and neural disease were
evaluated.
Since application of databases is emphasized to search
queries and knowledge making is restricted to in vivo stud-
ies. In this study, there was an emphasis on databases that
were effective for the exploitation of hypothesis includ-
ing suitable quires and appropriate criteria. Researches
have been carried out through gathering information and
queries including the new in silico approach and then in
vitro studies prior to in vivo investigation.
A categorized list of proteins and diseases based on
theoretical frameworks interpretation was proposed in-
cluding databases name, data type, contents, scope and
methodology, as identified from different databases (Table
1).
4. Results
Evolving bioinformatics tools based on experimental
experiences were identified in different bioinformatics
databases; exploiting of these information revealed that
the PMP2 could be related to different diseases. Priority
based on average scores in different databases such as Z
score was determined. This score was used as a confidence
value to interpret linkage rate of these proteins with other
diseases.
These diseases included neuritis (5.9), microsporid-
iosis (4.9), Pseudomyxoma peritonei (2.5), acute dissem-
inated encephalomyelitis (2.3), Charcot-Marie-Tooth dis-
ease (2.2), mumps (1.8), demyelinating polyneuropathy
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Table 1. Web Services Used in This Study
Name Data Types Brief of Content, Scope and Methodology URL
Expasy, Expert Protein Analysis System A wide range of resources in many different domains and
areas such as bioinformatics
Expert Protein Analysis System and Swiss Institute of
Bioinformatics (SIB) acted as a proteomics server to analyze
protein sequences and structures.
https://www.expasy.org/
HPRD, Human Protein Reference Database Centralized platform to visually depict and integrate
information pertaining to domain architecture
Protein-protein interaction
Human Protein Reference Database represented a
centralized platform to visually depict and integrate
information pertaining to domain architecture,
post-translational modifications, interaction networks and
disease association for each protein in the human
proteome. All the information had been manually
extracted from the literature by expert biologists who read,
interpreted and analyzed the published data.
http://www.humanproteinpedia.org/
KEGG, Kyoto Encyclopedia of Genes and Genomes Bioinformatics resource for deciphering the genome The Kyoto Encyclopedia of Genes and Genomes presented a
collection of disease entries capturing knowledge on
genetic and environmental perturbations.
http://www.genome.jp/kegg/disease/
NCBI, National Center for Biotechnology Information Molecular data and its cryptic and subtle patterns,
biomedical and genomic information
The National Center for Biotechnology Information
engaged, developed and coordinated access to a variety of
databases, medical communities, basic and applied
research in computational biology in informatics research
and provided an absolute requirement for computerized
databases and analysis tools
http://www.ncbi.nlm.nih.gov/
OMIM, Online Mendelian Inheritance in Man Genes, genetic disorders Online Mendelian Inheritance in Man, supported catalog
of all known human genes and genetic phenotypes.
http://www.omim.org/
PDB, Protein Data Bank Structural data of large biological molecules Protein Data Bank presented a key resource in areas of
structural biology, and biochemists.
http://www.pdb.org/pdb/home/home.do
PeptideAtlas, The Human PeptideAtlas Different peptide and protein The Human Peptide Atlas, establishment of a standard
method for the submission of data to the Proteome
Xchange consortium databases PRIDE, PeptideAtlas, and
Tranche
http://www.proteinatlas.org/
UniProtKB, UniPro Knowledge Protein annotation The Universal Protein resource Knowledge, a central hub by
combining the Swiss-Prot, TrEMBL and PIR-PSD databases
provided accurate, consistent and rich annotation. To
capturing the core data mandatory for each UniProtKB
entry (mainly, the amino acid sequence, protein name or
description, taxonomic data and citation information), as
much annotation information as possible was added.
http://www.uniprot.org/
(1.7), Cryptococcosis (1.7), and measles (1.3). The results of
exploited data revealed that PMP2 including 5.9 z, is the
most powerful protein involved in neuritis disease (Table
2).
On the other hand, evaluation of information in pro-
teomics databases combined with bioinformatics tools led
to isolated collection of protein classes, which were associ-
ated with neuritis. Interestingly, this collection has been
set base on Z score, too. Evidence displayed that PMP2, in-
cluding 5.9 z, is the most powerful protein and, Aminoacyl
tRNA synthetase complex-interacting multifunctional pro-
tein (AIMP1) is the protein (3.3z) with least power in neuritis
disorders (Table 3).
Moreover, the interpretation of results revealed that
leprosy, a neuroinfection disorder with high similarity
with neuritis (30.6 z) relative to other diseases, involves
IFNG protein (4.3 z), a secreted protein class, which is im-
portant in leprosy disease.
5. Discussion
Recent neuroinformatic and modeling of disease re-
searches have used computational bioinformatics for the
study of living organisms. These studies have highlighted
the beginning of a quiet revolution in bioscience, sys-
tem biology and reshuﬄing of disease considering pro-
tein classes (31). Interestingly, the combined evidence of va-
lidity and reliability between theoretical evaluations with
conducted experimental observations is a merit of the
bioinformatics methodology, which should be done prior
to laboratory tests.
In this study, there was an emphasis on bioinformatics
databases to present a hypothesis about the relationship
between protein classes and human disease. Furthermore,
the findings of the study were confirmed by interpretation
of several databases.
The hypothesis, which was confirmed based on theo-
retical studies, suggested that one protein could be related
to different diseases, and two different proteins could be
the causative agent of one, while two related diseases could
be associated with various protein classes and their pro-
tein classes could be different. These findings could indi-
cate the complexity of this subject.
Evidences of this study suggested that causes related to
human neuronal disease, are not only defective structural
and functional proteins but also the association of various
protein classes.
The evidence, based on the prognosis of this method,
revealed that the proposed agent in protein –related pre-
diction is not a single criterion such as Z score, MIFT score,
or protein family, but rather a collection of these crite-
ria are necessary. On the other hand, the results of differ-
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Table 2. The association of PMP2 with disorders
Name Z-Score Classification
PMP2 (Peripheral myelin protein 2) 5.9 Predicted intracellular proteins
EDA (Ectodysplasin A) 4.2 Cytoskeleton related proteins, Disease related genes, Predicted intracellular
proteins, Predicted membrane proteins
MLLT1 (Myeloid/lymphoid or mixed-lineage leukemia (trithorax
homolog, Drosophila); translocated to, 1)
4.1 Cancer-related genes, Disease related genes, Predicted intracellular proteins
CD40LG (CD40 ligand) 3.6 Cancer-related genes, CD markers, Disease related genes, Predicted
membrane proteins
MBP (Myelin basic protein) 3.6 Candidate cardiovascular disease genes, Disease related genes, Plasma
proteins, Predicted intracellular proteins
CD4 (CD4 molecule) 3.5 CD markers, FDA approved drug targets, Predicted membrane proteins
MAG (Myelin associated glycoprotein) 3.3 Plasma proteins, Predicted intracellular proteins, Predicted membrane
proteins
AIF1 (Allograft inflammatory factor 1) 3.3 Predicted intracellular proteins
LRP11 (Low density lipoprotein receptor-related protein 11) 3.3 Predicted membrane proteins, Predicted secreted proteins
AIMP1 (Aminoacyl tRNA synthetase complex-interacting
multifunctional protein 1)
3.3 Disease related genes, Predicted intracellular proteins
Table 3. The Association of Neuritis Disorder With Protein Class
Name Z-Score Classification Protein Classification
Neuritis 5.9 Neuronal diseases MPZ Disease related genes, Predicted intracellular
proteins, Predicted membrane proteins
Microsporidiosis 4.9 Rare diseases, Infectious diseases METAP2 Enzymes, FDA approved drug targets, Plasma
proteins
Pseudomyxoma peritonei 2.5 Rare diseases, Cancer diseases MUC2 Predicted secreted proteins
Acute disseminated encephalomyelitis 2.3 Rare diseases, Neuronal diseases MBP Candidate cardiovascular disease genes,
Disease related genes, Predicted intracellular
proteins
Charcot-Marie-Tooth disease 2.2 Genetic diseases, Rare diseases, Fetal diseases,
Metabolic diseases, Neuronal diseases, Ear
diseases
GJB1 Disease related genes, Potential drug targets,
Predicted membrane proteins, Transporters
Mumps 1.8 Rare diseases, Infectious diseases, Oral
diseases
STAT2 Transcription factors
Demyelinating polyneuropathy 1.7 Rare diseases, Neuronal diseases PMP22 Cancer-related genes, Disease related genes,
Predicted intracellular proteins, Predicted
membrane proteins
Cryptococcosis 1.7 Rare diseases, Infectious diseases SELL Cancer-related genes, Candidate
cardiovascular disease genes, CD markers,
Plasma proteins
Measles 1.3 Rare diseases, Infectious diseases, Skin
diseases
CD46 Cancer-related genes, CD markers, Disease
related genes, Plasma proteins, Predicted
membrane proteins
Abbreviations: CD46, CD46 molecule, complement regulatory protein; GJB1, Gap Junction Protein, Beta 1, 32kDa; MBP, myelin basic protein; METAP2, Methionyl
Aminopeptidase 2; MPZ, myelin protein zero; MUC2 Mucin 2, oligomeric mucus/Gel- forming; PMP22, peripheral myelin protein 22; SELL, selectin L; STAT2, signal Trans-
ducer and activator of transcription 2, 113kDa.
ent databases are confusing when considered separately.
Thus, one needs to focus on collection of databases and
development of comprehensive prediction, as previously
described in the result section. Accordingly, a set of pro-
teins and a panel of disorders were identified by the pro-
tein of each database. Overall, theoretical frameworks of
all the protein fragments were interpreted. All mentioned
evidences indicated the complexity of bioinformatics stud-
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ies.
In this study, research was carried out based on a new
theoretical approach exploited from bioinformatics tools.
This approach could help researchers predict and design
the study prior to investigation experimental studies. In
addition, it is effective as a new method for confirmation of
hypothesis of theoretical prediction and comprehensive
studies based on in silico integrative in vitro studies.
5.1. Conclusions
The results of interpreted data from different pro-
teomics databases suggested that two diseases that are re-
lated to each other, might involve different classes of pro-
teins. Hypothesis of silico-based investigation with consol-
idated prediction prior to in vivo studies could increase the
reliability of the study. Future researches should use bioin-
formatics for development of neuro-autoantigenic targets
for the reshuﬄing and the etiology of different diseases.
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